Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Mafenide

Base Information
  • Chemical Name:Mafenide
  • CAS No.:138-39-6
  • Molecular Formula:C7H10N2O2S
  • Molecular Weight:186.235
  • Hs Code.:2935009090
  • European Community (EC) Number:205-326-9
  • NSC Number:34632
  • UNII:58447S8P4L
  • DSSTox Substance ID:DTXSID6047860
  • Nikkaji Number:J812E
  • Wikipedia:Mafenide
  • Wikidata:Q3843044
  • NCI Thesaurus Code:C61819
  • RXCUI:6572
  • Pharos Ligand ID:TKLJJ81FKP8G
  • Metabolomics Workbench ID:67468
  • ChEMBL ID:CHEMBL419
  • Mol file:138-39-6.mol
Mafenide

Synonyms:4 Homosulfanilamide;4-Homosulfanilamide;Bensulfamide;Mafenide;Mafenide Acetate;Mafylon;Maphenid;Marfanil;Napaltan;Sulfabenzamine;Sulfamylon

Suppliers and Price of Mafenide
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • 4-Aminomethylbenzenesulfonamide
  • 250mg
  • $ 60.00
  • SynChem
  • 4-Aminomethylbenzenesulfonamide 95+%
  • 1 g
  • $ 50.00
  • SynChem
  • 4-Aminomethylbenzenesulfonamide 95+%
  • 10 g
  • $ 220.00
  • SynChem
  • 4-Aminomethylbenzenesulfonamide 95+%
  • 5 g
  • $ 150.00
  • Matrix Scientific
  • 4-(Aminomethyl)benzenesulfonamide
  • 25g
  • $ 440.00
  • Matrix Scientific
  • 4-(Aminomethyl)benzenesulfonamide
  • 5g
  • $ 150.00
  • Crysdot
  • Mafenide 98+%
  • 50mg
  • $ 40.00
  • Crysdot
  • Mafenide 98+%
  • 100mg
  • $ 59.00
  • Cayman Chemical
  • Mafenide Acetate ≥95%
  • 250mg
  • $ 54.00
  • Cayman Chemical
  • Mafenide Acetate ≥95%
  • 100mg
  • $ 39.00
Total 36 raw suppliers
Chemical Property of Mafenide
Chemical Property:
  • Melting Point:177-178℃ (decomposition) 
  • Boiling Point:382 °C at 760 mmHg 
  • PKA:10.16±0.10(Predicted) 
  • Flash Point:184.8 °C 
  • PSA:94.56000 
  • Density:1.345 g/cm3 
  • LogP:2.27410 
  • Storage Temp.:2-8°C 
  • Solubility.:DMSO (Slightly), Methanol (Slightly) 
  • XLogP3:-0.7
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:4
  • Rotatable Bond Count:2
  • Exact Mass:186.04629874
  • Heavy Atom Count:12
  • Complexity:224
Purity/Quality:

97% *data from raw suppliers

4-Aminomethylbenzenesulfonamide *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Canonical SMILES:C1=CC(=CC=C1CN)S(=O)(=O)N
  • Uses antibacterial
  • Therapeutic Function Antibacterial
Technology Process of Mafenide

There total 24 articles about Mafenide which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With hydrogenchloride; palladium 10% on activated carbon; hydrogen; In methanol; at 20 ℃; for 4h;
Guidance literature:
With palladium 10% on activated carbon; hydrogen; In methanol; for 16h;
Guidance literature:
With hydrogenchloride;
DOI:10.1021/ja01237a012
Refernces

Carbonic anhydrase inhibitors. Part 43. Schiff bases derived from aromatic sulfonamides: Towards more specific inhibitors for membrane-bound versus cytosolic isozymes

10.1016/S0223-5234(97)81681-9

The study investigates the development of more specific carbonic anhydrase (CA) inhibitors, focusing on Schiff bases derived from aromatic sulfonamides. The researchers synthesized 21 new Schiff bases using sulfanilamide, homosulfanilamide, and p-aminoethyl-benzenesulfonamide as starting materials, reacting them with various substituted benzene- and heterocyclic aldehydes. These compounds were characterized and tested for their inhibitory effects on three CA isozymes: CA I, CA II, and CA IV. The results showed that several of these new Schiff bases exhibited a modest two-fold selectivity for the membrane-bound CA IV compared to the cytosolic human isozymes CA I and II. This selectivity is attributed to a decreased potency against hCA II relative to classical inhibitors. The study suggests that these compounds could potentially lead to the development of low molecular weight, isozyme-specific CA IV inhibitors, which may have improved therapeutic profiles and fewer side effects.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 138-39-6